HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Schneider Selected Research

Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)

3/2015Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.
1/2013Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models.
10/2009Inflammatory breast cancer cells are constitutively adapted to hypoxia.
11/2007A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer.
7/2004Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J Schneider Research Topics

Disease

44Neoplasms (Cancer)
01/2022 - 05/2006
26Breast Neoplasms (Breast Cancer)
01/2022 - 05/2006
16Neoplasm Metastasis (Metastasis)
01/2022 - 12/2004
7Hypoxia (Hypoxemia)
07/2013 - 05/2006
5Melanoma (Melanoma, Malignant)
01/2022 - 08/2002
4Inflammatory Breast Neoplasms
01/2019 - 10/2009
4Ductal Carcinoma
01/2018 - 08/2012
3Carcinoma (Carcinomatosis)
01/2014 - 01/2013
2Ovarian Neoplasms (Ovarian Cancer)
09/2018 - 01/2016
2Hemorrhage
08/2017 - 11/2006
2Endometrial Neoplasms (Endometrial Cancer)
02/2014 - 12/2011
2Carcinogenesis
12/2010 - 01/2007
2Inflammation (Inflammations)
01/2010 - 09/2008
2Tuberous Sclerosis (Bourneville's Disease)
07/2008 - 05/2006
2Starvation
04/2008 - 11/2002
1Neuroinflammatory Diseases
01/2022
1Brain Neoplasms (Brain Tumor)
01/2022
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022
1Sarcopenia
09/2021
1Lymphoma (Lymphomas)
01/2021
1Atherosclerosis
01/2021
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021
1Meningioma (Meningiomas)
01/2021
1Neurilemmoma (Schwannoma)
01/2021
1Acoustic Neuroma (Acoustic Neurinoma)
01/2021
1Obesity
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2020
1Diabetes Mellitus
07/2020
1Alzheimer Disease (Alzheimer's Disease)
07/2020
1Stroke (Strokes)
07/2020
1Noncommunicable Diseases
07/2020
1Parkinson Disease (Parkinson's Disease)
07/2020
1Chronic Obstructive Pulmonary Disease (COPD)
07/2020
1Heart Diseases (Heart Disease)
07/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2020
1Triple Negative Breast Neoplasms
11/2018
1Ovarian Epithelial Carcinoma
09/2018
1Esophageal Fistula
08/2017
1Atrial Fibrillation
08/2017

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2003
8Peptide Initiation Factors (Initiation Factor)IBA
01/2018 - 11/2007
7Messenger RNA (mRNA)IBA
09/2021 - 11/2002
7DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2010
6Mechanistic Target of Rapamycin Complex 1IBA
01/2021 - 02/2014
5Eukaryotic Initiation Factor-4EIBA
01/2022 - 07/2004
5Estrogen ReceptorsIBA
11/2017 - 07/2006
5Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA
03/2015 - 07/2004
5CytokinesIBA
01/2015 - 11/2006
5Phosphotransferases (Kinase)IBA
02/2014 - 05/2006
5Cadherins (E-Cadherin)IBA
01/2013 - 08/2002
4Carboplatin (JM8)FDA LinkGeneric
01/2022 - 02/2014
4EverolimusFDA Link
01/2021 - 02/2014
4ChemokinesIBA
01/2019 - 09/2008
4Internal Ribosome Entry SitesIBA
01/2016 - 11/2007
3PlatinumIBA
01/2022 - 01/2016
3Pharmaceutical PreparationsIBA
01/2021 - 01/2009
3Oxygen (Dioxygen)IBA
10/2009 - 05/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009 - 11/2006
2Serine (L-Serine)FDA Link
01/2021 - 11/2020
2Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 01/2016
2Estrogens (Estrogen)FDA Link
11/2017 - 11/2010
2TamoxifenFDA LinkGeneric
11/2017 - 01/2017
2Biomarkers (Surrogate Marker)IBA
04/2016 - 05/2012
2Endothelin-1 (Endothelin 1)IBA
01/2016 - 08/2002
2PP242IBA
01/2016 - 02/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 10/2009
2Small Interfering RNA (siRNA)IBA
03/2015 - 11/2010
2CD146 AntigenIBA
08/2014 - 12/2004
2Hormones (Hormone)IBA
08/2012 - 12/2010
2Steroid Receptors (Steroid Receptor)IBA
07/2011 - 11/2010
2Androgen Receptors (Androgen Receptor)IBA
07/2011 - 12/2010
2Paclitaxel (Taxol)FDA LinkGeneric
12/2010 - 01/2010
2Pyridinolcarbamate (P23)IBA
11/2010 - 07/2006
2CateninsIBA
10/2009 - 08/2002
1Amyloid beta-PeptidesIBA
01/2022
1SBI-0640756IBA
01/2021
1venetoclaxIBA
01/2021
1Eukaryotic Initiation Factor-4F (EIF4F)IBA
01/2021
1Transfer RNA (tRNA)IBA
01/2021
1larotrectinibIBA
11/2020
1Codon (Codons)IBA
11/2020
1Nerve Growth Factor (NGF)IBA
11/2020
1Eukaryotic Initiation Factor-2 (EIF 2)IBA
07/2020
1Interleukin-8 (Interleukin 8)IBA
01/2019
1Immunologic Factors (Immunomodulators)IBA
01/2019
1CyclinsIBA
01/2019
1PlasticsIBA
01/2018

Therapy/Procedure

11Therapeutics
01/2019 - 09/2008
5Drug Therapy (Chemotherapy)
09/2018 - 01/2008
3Radiotherapy
12/2010 - 10/2007
2Mastectomy (Mammectomy)
01/2018 - 01/2015
2Aftercare (After-Treatment)
01/2016 - 02/2014
1Thoracotomy
08/2017
1Catheters
08/2017
1Cryosurgery
08/2017
1Radiofrequency Ablation
08/2017
1Transcatheter Aortic Valve Replacement
05/2017